Do inhaled corticosteroids elevate risk for pneumonia in patients with chronic obstructive pulmonary disease? Several clinical trials, observational studies, and meta-analyses suggest that they do ...

When you have COPD, your lifestyle has a major impact on the severity and progression of your illness. Every treatment plan should start with healthy lifestyle changes. Medications alone should not be ...

COPD is among the leading causes of death in industrialized countries, and new pharmacological treatments are being developed to help patients with this disease. But a spectrum of non-pharmacological ...

The CRYSTAL trial is the first large-scale study exploring the effects of directly switching symptomatic, non-frequently ... from other COPD treatments, such as inhaled steroid-containing ...

Verona Pharma (Nasdaq: VRNA) is already recording millions of dollars in revenue after launching its lead drug in August ...

One in 13 Australians over the age of 40 has chronic obstructive pulmonary disease or COPD but, alarmingly, only half of them ...

End-stage chronic obstructive pulmonary disease (COPD) refers to being in the final ... Some combination inhalers include both of these categories of medication in a single inhaler. Short-acting ...

Marketed in the past by AstraZeneca as Pulmicort, budesonide is an off-patent inhaled steroid and could be used ... obstructive pulmonary disease (COPD) were surprisingly underrepresented among ...

In 2017, the FDA approved the removal of the boxed warning on all combination steroid/LABA inhalers. Taking higher doses of ...

Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3Through October more than 2,200 unique ...